SOURCE: BioElectronics Corporation

September 08, 2010 08:30 ET

BioElectronics Names Stacy Wood, Ph.D., to Board of Directors

Leading Consumer Marketing Researcher in Pharmaceutical Market

FREDERICK, MD--(Marketwire - September 8, 2010) -  BioElectronics Corporation (PINKSHEETS: BIEL), developers of innovative pain-relieving medical devices, today announced the addition of Dr. Stacy Wood to its Board of Directors.

Dr. Stacy Wood is an internationally recognized scholar in the study of new product development and the psychology of consumers' innovation adoption. Her recent projects have investigated how to improve consumer learning of new product information, how consumers in flux embrace change, and how consumers deal with complex medical/pharmaceutical innovations. Her work has been published in Journal of Consumer Research, Journal of Marketing Research, Journal of Marketing, Journal of Consumer Psychology and Journal of Retailing. Additionally, she has won numerous significant research awards from top institutions such as the American Marketing Association, including the MSI/H Paul Root Award in 1997 and the Louis W. Stern Award in 2005. 

Dr. Wood earned her Ph.D. at the University of Florida in 1998 and currently serves as the Langdon Distinguished Professor of Marketing at North Carolina State University's College of Management. Previous to joining NC State in 2010, she was on the faculty at the University of South Carolina where she founded the USC Center for Neuroeconomic Research. At NC State, Dr. Wood is developing a corporate center for consumer innovation insight to better understand and facilitate the business practices that encourage individuals and societies to embrace growth and change.

"We first got to know Dr. Wood when she provided us unique guidance on how to market and position our Allay™ Menstrual Pain Therapy product. We were greatly impressed with her insights and her significant consulting experience in the healthcare industry. Thus we were extremely pleased that she has agreed to join our team," said Dr. Richard Staelin, Chairman of the Board of BioElectronics Corporation. "We believe her addition to the Board will significantly enhance our ability to understand how consumers perceive our innovative anti-inflammatory and pain management products and thus our ability to successfully launch our products throughout the globe."

About BioElectronics Corporation
BioElectronics Corporation (PINKSHEETS: BIEL) is the maker of safe, inexpensive, drug-free medical devices and patches that deliver pulsed electromagnetic energy to relieve pain and inflammation. The Company's wafer thin patches contain an embedded microchip and battery that deliver pulsed electromagnetic energy, a clinically proven and widely accepted anti-inflammatory and pain relief therapy that heretofore has only been possible to obtain from large, facility-based equipment. BioElectronics markets and sells its current products under the brand names ActiPatch™, RecoveryRx™, Allay™ Menstrual Pain Therapy and HealFast™ Therapy for cats, dogs and horses. The Company is headquartered in Frederick, MD. For more information, visit www.bielcorp.com.

Contact Information